United Kingdom alcohol treatment trial (UKATT): hypotheses, design and methods

TitleUnited Kingdom alcohol treatment trial (UKATT): hypotheses, design and methods
Publication TypeJournal Article
Year of Publication2001
AuthorsUKATT Research Team,
JournalAlcohol and Alcoholism
Volume36
Pagination11-21
Date PublishedJan-Feb
Publication Languageeng
ISBN Number0735-0414 (Print)0735-0414 (Linking)
Accession Number11139410
Keywords*Social Environment, Alcoholism/economics/psychology/*therapy, Great Britain/epidemiology, Humans, Multicenter Studies as Topic/economics/*methods/psychology, Outcome Assessment (Health Care)/methods, Randomized Controlled Trials as Topic/economics/*methods/psychology
Abstract

The United Kingdom Alcohol Treatment Trial (UKATT) is intended to be the largest trial of treatment for alcohol problems ever conducted in the UK. UKATT is a multicentre, randomized, controlled trial with blind assessment, representing a collaboration between psychiatry, clinical psychology, biostatistics, and health economics. This article sets out, in advance of data analysis, the theoretical background of the trial and its hypotheses, design, and methods. A projected total of 720 clients attending specialist services for treatment of alcohol problems will be randomized to Motivational Enhancement Therapy (MET) or to Social Behaviour and Network Therapy (SBNT), a novel treatment developed for the trial with strong support from theory and research. The trial will test two main hypotheses, expressed in null form as: (1) less intensive, motivationally based treatment (MET) is as effective as more intensive, socially based treatment (SBNT); (2) more intensive, socially based treatment (SBNT) is as cost-effective as less intensive, motivationally based treatment (MET). A number of subsidiary hypotheses regarding client-treatment interactions and therapist effects will also be tested. The article describes general features of the trial that investigators considered desirable, namely that it should: (1) be a pragmatic, rather than an explanatory, trial; (2) be an effectiveness trial based on "real-world" conditions of treatment delivery; (3) incorporate high standards of training, supervision and quality control of treatment delivery; (4) pay close attention to treatment process as well as treatment outcome; (5) build economic evaluation into the design at the outset. First results from UKATT are expected in 2002 and the main results in 2003.

URLhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11139410
Go to top